Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease

Completed · Phase 3 · Has a placebo group

Conditions studied: Cushing's Disease

In brief

The purpose of this study was to confirm efficacy and safety of osilodrostat for the treatment of patients with Cushing's disease who are candidates for medical therapy.

Key facts

Study ID

NCT02697734

Run by

Novartis Pharmaceuticals

People needed

73

Starts

2016-10-03

Expected to finish

2020-12-31

Last updated by the study team

2021-11-01

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Colorado Endocrinology Clinical Trials Unit — Aurora, Colorado, United States
• University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
• Columbia University Medical Center New York Presbyterian Neuroendocrine Unit — New York, New York, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• Oregon Health and Science University SC LCI699C2301 — Portland, Oregon, United States
• University of Pennsylvania Medical Center University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Novartis Investigative Site — Leuven, Belgium
• Novartis Investigative Site — Fortaleza, Ceará, Brazil
• Novartis Investigative Site — Rio de Janeiro, Rio de Janeiro, Brazil
• Novartis Investigative Site — São Paulo, São Paulo, Brazil
• Novartis Investigative Site — São Paulo, São Paulo, Brazil
• Novartis Investigative Site — Halifax, Nova Scotia, Canada
• Novartis Investigative Site — Montreal, Quebec, Canada
• Novartis Investigative Site — Sherbrooke, Quebec, Canada
• Novartis Investigative Site — Chengdu, Sichuan, China
• Novartis Investigative Site — Beijing, China
• Novartis Investigative Site — Beijing, China
• Novartis Investigative Site — Guangzhou, China
• Novartis Investigative Site — San Pedro, San Jose, Costa Rica, Costa Rica
• Novartis Investigative Site — Athens, Greece
• Novartis Investigative Site — Warsaw, Masovian Voivodeship, Poland
• Novartis Investigative Site — Krakow, Poland
• Novartis Investigative Site — Warsaw, Poland
• Novartis Investigative Site — Porto, Portugal
• Novartis Investigative Site — Moscow, Russia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.